Glass Quality Crisis Prompts Multi-Faceted Array of Risk-Based Improvements

Drug makers, glass suppliers and FDA officials who attended a recent Parenteral Drug Association glass quality conference made some progress toward understanding why glass-related recalls have surged and what corrective and preventive measures they should apply.